IGF1 and Parkinson disease: In order to examine and investigate the improvement in motor function and the impact of resagiline and levodopa and benserazide hydrochloride on serum Hcy and IGF-1 levels in patients with intermediate and advanced PD, this study will adopt a retrospective methodology.